Product Images Otezla

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Otezla NDC 55513-137 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The chemical structure for OTEZLA tablets is apremilast. Apremilast is a phosphodiesterase 4 (PDE4) inhibitor. Apremilast is known chemically as N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide. Its empirical formula is C22H24N2O7S and the molecular weight is 460.5. - otezla 01

Figure 1: Mean (± SE) Number of Oral Ulcers by Time Point Through Week 12 (ITT Population) - otezla 02

Figure 2: Mean (± SE) Oral Ulcer Pain on a Visual Analog Scale by Time Point Through Week 12 (ITT Population) - otezla 03

PDP image for 55513-137-28:NDC 55513-137-28Rx OnlyOtezla®(apremilast) tabletsAmgen®28 tablets30 mg per tablet - otezla 04

The text describes a graph showing the mean number of oral ulcers over time (in weeks) for a placebo group and a group taking TEZLA 30 mg twice daily. It is not clear what type of study or condition is being investigated.*

PDP image for 55513-137-60:NDC 55513-137-60Otezla®(apremilast) tablets30 mgRx Only60 TabletsPatent: https://pat.amgen.com/otezlaStore below 30°C (86°F)Dosage: The recommended doseis a 30 mg tablet taken by mouthtwice daily.See full Prescribing Informationfor dosing and administration.Otezla® is registered trademarkof Amgen Inc.Manufactured for:Amgen Inc.Thousand Oaks, CA 91320-1799 U.S.A.Amgen®©2014-2015, 2020 Amgen Inc.All rights reservned.MADE IN SWITZERLAND - otezla 05

This is a graph showing the mean oral ulcer pain of a certain medication (Otezla 30mg twice daily) compared to a placebo over the duration of several weeks. The pain is measured on a scale of 0 to 100.*

PDP image for 55513-369-55:NDC 55513-369-55Rx OnlyOtezla®(apremilast) tablets28 DayStarter PackThis pack contains the followingfor tritration over 5 days up to theprescribed dose of 30 mg:Four - 10 mg tabletsFour - 20 mg tabletsForty-seven - 30 mg tablets55 TABLETSAmgen® - otezla 06

This is a medication package containing 98 tablets of Otezla (apremilast) manufactured by Amgen with a National Drug Code of 55513-137-28. The packaging features the brand name RcOnly and lists the cost per tablet, but no additional information is available.*

PDP image for 55513-485-95:NDC 55513-485-95Rx OnlyOtezla®(apremilast) tabletsStarter PackSAMPLE - NOT FOR SALEThis pack contains the followingfor titration over 5 days up to theprescribed dose of 30 mg:Four - 10 mg tabletsFour - 20 mg tabletsNineteen - 30 mg tablets27 TABLETSAmgen® - otezla 07

This text provides information regarding the medication Otezla (apremilast) tablets with the NDC code 55513-137-60. It also provides directions on how to store the tablets and recommends consulting full prescribing information for proper dosage and administration information. The text mentions that Otezla is a registered trademark of Amgen Inc. and the medication is manufactured in Switzerland. Finally, the text lists the patent for Otezla and provides copyright information for Amgen Inc.*

PDP image for 55513-485-96:NDC 55513-485-96Rx OnlyStarter PackSAMPLE - NOT FOR SALEEach pack contains the following for titration over5 days up to the prescribed dose of 30 mg:Four - 10 mg tabletsFour - 20 mg tabletsNineteen - 30 mg tabletsFive starter packs each containing 27 TABLETSOtezla®(apremilast) tabletsAmgen® - otezla 08

otezla 09

These are tablets of Apremilast, with NDC 55513-369-55, available in a Starter Pack. The pack contains four 10 mg tablets, four 20 mg tablets, and forty-seven 30 mg tablets, which should be gradually titrated over 5 days up to the prescribed dose of 30 mg. The manufacturer of these tablets is AMGEN®.*

otezla 10

This is a description for a starter pack of Otezla, a drug with the generic name Apremilast. This pack is not available for sale and is intended for titration purposes over a 5-day period to reach the prescribed dose of 30mg. The pack contains a total of 27 tablets, including 4 tablets of 10mg, 4 tablets of 20mg, and 19 tablets of 30mg. The NDC code for this drug is 55513-485-95.*

otezla 11

This is a starter pack for Otezla, manufactured by Amgen, identified by the National Drug Code (NDC) 55513-485-96. It is not available for sale as it is labeled as a sample. The pack includes a total of 27 tablets for titration over, including four 10mg tablets, four 20mg tablets, and nineteen 30mg tablets.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.